INDV
Indivior Pharmaceuticals, Inc.
35.90$
-0.8%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | -27.5% | +2.7% | -50.2% | -227.8% | – | -101.1% | – | – | -175.0% | |
| – | -7.1% | +23.1% | +75.0% | -7.1% | -15.4% | -27.3% | -6.3% | +86.7% | -28.6% | |
| – | +60.0% | -6.3% | -80.0% | +166.7% | +37.5% | +45.5% | +31.3% | +14.3% | +8.3% | |
| – | – | – | – | -176.5% | – | – | – | – | – | |
| – | -58.3% | -79.4% | -372.4% | – | – | -31.8% | -351.7% | – | – | |
| – | +22.9% | -4.7% | -82.9% | -42.9% | +750.0% | -85.3% | +960.0% | -41.5% | +116.1% | |
| – | +22.9% | -90.7% | -50.0% | +100.0% | +250.0% | +1,485.7% | -57.2% | – | -195.7% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -10.9% | -63.3% | +424.2% | -93.6% | |
| – | – | – | – | -15.4% | – | -300.0% | +0.0% | – | -118.5% | |
| – | -42.9% | +182.1% | -94.5% | -23.1% | +840.0% | +7.4% | -36.6% | +59.4% | -70.6% | |
| – | -24.0% | -64.3% | +123.0% | -248.5% | – | -234.4% | – | – | -4,233.3% | |
| – | -32.3% | +4.0% | -45.0% | -236.8% | – | -102.8% | – | – | -1,980.0% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.